Treatment of medication overuse headache—A review.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 405, doi. 10.1111/ane.13074
- By:
- Publication type:
- Article
Works matching IS 00016314 AND DT 2019 AND VI 139 AND IP 5
Results: 12
1
2
Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 438, doi. 10.1111/ane.13073
- By:
- Publication type:
- Article
3
Autoantibodies in acquired myasthenia gravis: Clinical phenotype and immunological correlation.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 428, doi. 10.1111/ane.13071
- By:
- Publication type:
- Article
4
Prognosis for intracerebral hemorrhage during ongoing oral anticoagulant treatment.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 415, doi. 10.1111/ane.13068
- By:
- Publication type:
- Article
5
MUL1 gene polymorphisms and Parkinson's disease risk.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 483, doi. 10.1111/ane.13081
- By:
- Publication type:
- Article
6
Investigative practice into sudden death in epilepsy: A global survey.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 476, doi. 10.1111/ane.13080
- By:
- Publication type:
- Article
7
Structural and functional connectivity in newly diagnosed juvenile myoclonic epilepsy.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 469, doi. 10.1111/ane.13079
- By:
- Publication type:
- Article
8
Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 462, doi. 10.1111/ane.13078
- By:
- Publication type:
- Article
9
Statins and the risk of bleeding in patients taking dabigatran.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 455, doi. 10.1111/ane.13077
- By:
- Publication type:
- Article
10
Therapeutic drug monitoring of gabapentin in various indications.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 446, doi. 10.1111/ane.13075
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 403, doi. 10.1111/ane.12985
- Publication type:
- Article
12
Cerebrospinal fluid NCAM levels are modulated by disease‐modifying therapies.
- Published in:
- Acta Neurologica Scandinavica, 2019, v. 139, n. 5, p. 422, doi. 10.1111/ane.13069
- By:
- Publication type:
- Article